Literature DB >> 26782789

Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.

R Sacco1, G Santangelo2, S Stamenova1,3, A Bisecco1, S Bonavita1, L Lavorgna1, L Trojano2,4, A D'Ambrosio1, G Tedeschi1,5, A Gallo1.   

Abstract

BACKGROUND AND
PURPOSE: Depression is the most common psychiatric disorder in multiple sclerosis (MS). Self-report depression scales are frequently used as screening, diagnostic and grading instruments. This study investigated the psychometric properties of the Beck Depression Inventory second edition (BDI-II) for assessing depressive disorders in a sample of Italian MS patients.
METHODS: The sample included 141 consecutive non-demented MS patients who completed the BDI-II and the Chicago Multiscale Depression Inventory (CMDI). MS patients also completed a clinical interview, a neurological/neuropsychological examination and a Fatigue Severity Score (FSS) questionnaire in order to assess divergent validity.
RESULTS: The BDI-II showed good internal consistency (Cronbach's alpha 0.89) and good convergent and divergent validity. With respect to CMDI serving as the 'gold standard', the receiver operating characteristic curve revealed that BDI-II is an adequate diagnostic measure and that the optimum total cut-off score was 18.5. Such score identified clinically relevant depressive symptoms in 25.5% of our MS sample.
CONCLUSIONS: The BDI-II is a simple, reliable and valid tool for detecting and grading depressive symptoms in Italian MS patients.
© 2016 EAN.

Entities:  

Keywords:  Beck Depression Inventory II; Chicago Multiscale Depression Inventory; depression; multiple sclerosis

Mesh:

Year:  2016        PMID: 26782789     DOI: 10.1111/ene.12932

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  21 in total

1.  Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.

Authors:  Fabio Basta; Domenico Paolo Emanuele Margiotta; Carmen Mazzuca; Veronica Batani; Giulio Dolcini; Patrizio Moras; Marta Vadacca; Antonella Afeltra
Journal:  Rheumatol Int       Date:  2018-11-29       Impact factor: 2.631

2.  Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis.

Authors:  Domenico Paolo Emanuele Margiotta; Alice Laudisio; Luca Navarini; Fabio Basta; Carmen Mazzuca; Silvia Angeletti; Massimo Ciccozzi; Raffaele Antonelli Incalzi; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2019-01-28       Impact factor: 2.980

3.  Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis.

Authors:  Eleonora Virgilio; Domizia Vecchio; Ilaria Crespi; Chiara Puricelli; Paolo Barbero; Giulia Galli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  J Neurol       Date:  2022-01-28       Impact factor: 4.849

Review 4.  Psychometrics, diagnostics and usability of Italian tools assessing behavioural and functional outcomes in neurological, geriatric and psychiatric disorders: a systematic review.

Authors:  Edoardo Nicolò Aiello; Alfonsina D'Iorio; Sonia Montemurro; Gianpaolo Maggi; Chiara Giacobbe; Valentina Bari; Gianluca Scotto Di Tella; Francesca Pischedda; Nadia Bolognini; Ildebrando Appollonio; Giorgio Arcara; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2022-08-06       Impact factor: 3.830

5.  Depression screening using mobile phone usage metadata: a machine learning approach.

Authors:  Rouzbeh Razavi; Amin Gharipour; Mojgan Gharipour
Journal:  J Am Med Inform Assoc       Date:  2020-04-01       Impact factor: 4.497

6.  Depression in myasthenia gravis: a heterogeneous and intriguing entity.

Authors:  Yury V Gavrilov; Tatjana M Alekseeva; Olga A Kreis; Philipp O Valko; Konrad P Weber; Yulia Valko
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

7.  Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek
Journal:  Clin Auton Res       Date:  2018-09-12       Impact factor: 4.435

Review 8.  Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it.

Authors:  Nathalie Jetté; Farnaz Amoozegar; Scott B Patten
Journal:  Neurol Clin Pract       Date:  2017-04

9.  Is the association between health-related quality of life and fatigue mediated by depression in patients with multiple sclerosis? A Spanish cross-sectional study.

Authors:  Juan J Fernández-Muñoz; Margarita Cigarán-Méndez; Esperanza Navarro-Pardo; Marta Pérez-de-Heredia-Torres; Paula Parás-Bravo; César Fernández-de-Las-Peñas
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

10.  Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study.

Authors:  Ester Riepl; Steffen Pfeuffer; Tobias Ruck; Hubertus Lohmann; Heinz Wiendl; Sven G Meuth; Andreas Johnen
Journal:  Front Neurol       Date:  2018-01-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.